{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD11c : Questions médicales les plus fréquentes",
"headline": "Antigènes CD11c : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antigènes CD11c : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antigènes CD11c"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Intégrine alphaX bêta2",
"url": "https://questionsmedicales.fr/mesh/D016167",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alphaX bêta2",
"code": {
"@type": "MedicalCode",
"code": "D016167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.301.350.275"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD11c",
"alternateName": "CD11c Antigen",
"code": {
"@type": "MedicalCode",
"code": "D039521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lifei Hou",
"url": "https://questionsmedicales.fr/author/Lifei%20Hou",
"affiliation": {
"@type": "Organization",
"name": "Cardiac Anesthesia Division, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA."
}
},
{
"@type": "Person",
"name": "Koichi Yuki",
"url": "https://questionsmedicales.fr/author/Koichi%20Yuki",
"affiliation": {
"@type": "Organization",
"name": "Cardiac Anesthesia Division, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA."
}
},
{
"@type": "Person",
"name": "Wakiro Sato",
"url": "https://questionsmedicales.fr/author/Wakiro%20Sato",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Immunology (E.A., W.S., A.K., T. Yamamura), National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo; Department of Neurology and Neurological Sciences (E.A., T. Yokota), Tokyo Medical and Dental University, Bunkyo; Department of Radiology (Y.K., N.S.); and Department of Neurology (Y.L., T.O.), National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Youwei Lin",
"url": "https://questionsmedicales.fr/author/Youwei%20Lin",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Immunology (E.A., W.S., A.K., T. Yamamura), National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo; Department of Neurology and Neurological Sciences (E.A., T. Yokota), Tokyo Medical and Dental University, Bunkyo; Department of Radiology (Y.K., N.S.); and Department of Neurology (Y.L., T.O.), National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Tomoko Okamoto",
"url": "https://questionsmedicales.fr/author/Tomoko%20Okamoto",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Immunology (E.A., W.S., A.K., T. Yamamura), National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo; Department of Neurology and Neurological Sciences (E.A., T. Yokota), Tokyo Medical and Dental University, Bunkyo; Department of Radiology (Y.K., N.S.); and Department of Neurology (Y.L., T.O.), National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Hot dots - which nodes should be removed in sentinel lymph node biopsy for melanoma?",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37493624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0284186X.2023.2238558"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36809608",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1245/s10434-023-13231-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lymph node stain after radical resection of rectal cancer mainly increased the harvest of mini lymph node: A randomized controlled trial.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800120",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00384-023-04323-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prognostic value of the lymph node ratio in surgically treated stage III colorectal cancer patients with high numbers of harvested lymph nodes.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35849005",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/00015458.2022.2103247"
}
},
{
"@type": "ScholarlyArticle",
"name": "Axillary lymph node dissection: Dead or still alive?",
"datePublished": "2023-01-23",
"url": "https://questionsmedicales.fr/article/36702672",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.breast.2023.01.009"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Antigènes de surface",
"item": "https://questionsmedicales.fr/mesh/D000954"
},
{
"@type": "ListItem",
"position": 5,
"name": "Molécules d'adhérence cellulaire",
"item": "https://questionsmedicales.fr/mesh/D015815"
},
{
"@type": "ListItem",
"position": 6,
"name": "Intégrine alphaX bêta2",
"item": "https://questionsmedicales.fr/mesh/D016167"
},
{
"@type": "ListItem",
"position": 7,
"name": "Antigènes CD11c",
"item": "https://questionsmedicales.fr/mesh/D039521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antigènes CD11c - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antigènes CD11c",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antigènes CD11c",
"description": "Comment diagnostiquer une expression anormale de CD11c ?\nQuels tests sont utilisés pour détecter les antigènes CD11c ?\nLes antigènes CD11c sont-ils spécifiques à certaines maladies ?\nQuelle est l'importance des antigènes CD11c dans le diagnostic ?\nPeut-on mesurer les niveaux de CD11c dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D039521?mesh_terms=Lymph+Node+Excision&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antigènes CD11c",
"description": "Quels symptômes sont associés à une surexpression de CD11c ?\nLa présence de CD11c est-elle liée à des symptômes spécifiques ?\nLes antigènes CD11c sont-ils liés à des symptômes neurologiques ?\nComment les symptômes varient-ils selon les niveaux de CD11c ?\nLes symptômes d'une maladie liée à CD11c sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D039521?mesh_terms=Lymph+Node+Excision&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antigènes CD11c",
"description": "Peut-on prévenir les maladies liées à CD11c ?\nY a-t-il des vaccins liés aux antigènes CD11c ?\nComment le dépistage précoce aide-t-il à prévenir les complications ?\nLes habitudes alimentaires influencent-elles CD11c ?\nLe stress a-t-il un impact sur CD11c ?",
"url": "https://questionsmedicales.fr/mesh/D039521?mesh_terms=Lymph+Node+Excision&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antigènes CD11c",
"description": "Quels traitements ciblent les antigènes CD11c ?\nLes traitements sont-ils efficaces contre les maladies liées à CD11c ?\nY a-t-il des effets secondaires aux traitements ciblant CD11c ?\nComment les traitements sont-ils adaptés aux niveaux de CD11c ?\nLes traitements sont-ils disponibles pour tous les patients ?",
"url": "https://questionsmedicales.fr/mesh/D039521?mesh_terms=Lymph+Node+Excision&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antigènes CD11c",
"description": "Quelles complications peuvent survenir avec CD11c élevé ?\nLes complications sont-elles réversibles ?\nComment gérer les complications liées à CD11c ?\nLes complications affectent-elles la qualité de vie ?\nY a-t-il des risques de complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D039521?mesh_terms=Lymph+Node+Excision&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antigènes CD11c",
"description": "Quels sont les facteurs de risque pour CD11c élevé ?\nL'âge influence-t-il les niveaux de CD11c ?\nLe mode de vie affecte-t-il les niveaux de CD11c ?\nLe stress est-il un facteur de risque pour CD11c ?\nLes infections antérieures influencent-elles CD11c ?",
"url": "https://questionsmedicales.fr/mesh/D039521?mesh_terms=Lymph+Node+Excision&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une expression anormale de CD11c ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse se fait par cytométrie en flux pour évaluer l'expression de CD11c sur les cellules."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les antigènes CD11c ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests immunologiques comme l'immunofluorescence et la cytométrie en flux sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antigènes CD11c sont-ils spécifiques à certaines maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur expression est souvent associée à des maladies comme la leucémie ou le lupus."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des antigènes CD11c dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier certains sous-types de cellules immunitaires et à diagnostiquer des pathologies."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les niveaux de CD11c dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de CD11c peuvent être mesurés dans le sang par des techniques de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une surexpression de CD11c ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des manifestations immunitaires comme des infections récurrentes."
}
},
{
"@type": "Question",
"name": "La présence de CD11c est-elle liée à des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surexpression peut être liée à des symptômes d'auto-immunité ou d'inflammation."
}
},
{
"@type": "Question",
"name": "Les antigènes CD11c sont-ils liés à des symptômes neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent un lien potentiel entre CD11c et des troubles neurologiques dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les niveaux de CD11c ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés peuvent entraîner des symptômes plus graves d'inflammation ou d'auto-immunité."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une maladie liée à CD11c sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la maladie sous-jacente; certains symptômes peuvent être réversibles avec traitement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées à CD11c ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives comme un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins liés aux antigènes CD11c ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques ciblant les antigènes CD11c."
}
},
{
"@type": "Question",
"name": "Comment le dépistage précoce aide-t-il à prévenir les complications ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce permet d'identifier les anomalies et d'initier un traitement rapide."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles CD11c ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut moduler la réponse immunitaire et l'expression de CD11c."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur CD11c ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction immunitaire et l'expression de CD11c."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les antigènes CD11c ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies immunomodulatrices et des anticorps monoclonaux peuvent cibler CD11c."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre les maladies liées à CD11c ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent réduire l'inflammation et améliorer les symptômes associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ciblant CD11c ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des réactions allergiques ou des infections peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils adaptés aux niveaux de CD11c ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont ajustés en fonction des niveaux de CD11c et de la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils disponibles pour tous les patients ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'accès aux traitements peut varier selon les pays et les systèmes de santé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec CD11c élevé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections graves ou des maladies auto-immunes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à CD11c ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi médical régulier et des traitements adaptés aux symptômes."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de complications chroniques existent, surtout en cas de maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour CD11c élevé ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux de maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de CD11c ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut influencer l'expression de CD11c et la réponse immunitaire globale."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il les niveaux de CD11c ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les niveaux de CD11c."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque pour CD11c ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter l'expression de CD11c et affecter la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Les infections antérieures influencent-elles CD11c ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections antérieures peuvent moduler l'expression de CD11c et la réponse immunitaire."
}
}
]
}
]
}
Sentinel lymph node biopsy (SLNB) is a critical staging tool for melanoma patients. The optimal number of lymph nodes removed in SLNB remains unclear. In this study, we retrospectively analysed and te...
The study population consisted of melanoma patients undergoing SLNB. During the operation all radioactive and blue nodes were removed and sent for histopathological analysis. The...
Altogether 175 patients with clinically occult metastasis presented with one or more positive, i.e. metastatic, SLNs. The mean number of lymph nodes removed was 4.5, and the mean number of positive ly...
By removing the hottest node and all nodes with radioactivity >10% of the hottest node, 97% of patients with SLN metastases are correctly staged with or without using blue dye....
In clinically node-negative (cN0) early stage breast cancer (EBC) undergoing primary systemic treatment (PST), post-treatment positive sentinel lymph node (SLN+) directs axillary lymph node dissection...
We conducted an observational study on imaging-confirmed cN0 EBC, who underwent PST and breast surgery that resulted in SLN+ and underwent ALND. The association among baseline/postsurgical clinic-path...
Non-SLN+ were detected in 22.2% cases after ALND. Only progesterone receptor (PR) levels and macrometastatic SLN+ were independently associated to non-SLN+. LR identified PR, Ki67, and type and number...
In cN0 EBC with post-PST SLN+, non-SLN+ at ALND are infrequent (~22%) and independently associated to PR levels and macrometastatic SLN. ALND-predict multiparametric score accurately predicted absence...
The lymph node status plays an important role in rectal cancer, which depends on adequate lymph node harvest. Lymph node stain techniques increase the lymph node harvest. The aim of this prospective s...
From May 2020 to May 2022, 172 stage II-III rectal cancer patients were randomized to methylene blue (MB) stained group or unstained group to retrieve the lymph nodes. Methylene blue solution was inje...
The number of lymph nodes harvested with MB was significantly higher (22.0 (14.8, 32.0) vs 14.5 (11.0, 22.0); p < 0.001) without difference in positive patients or number of positive nodes. The positi...
Intra-arterial injection of MB can significantly increase the number of lymph nodes harvested in rectal cancers, especially those mini lymph nodes. However, methylene blue staining did not significant...
The lymph node ratio (LNR), defined as the number of positive lymph nodes (LN) divided by the total number of harvested LN, has been demonstrated to be an independent factor in the prognosis of surgic...
Stage III CRC patients who underwent curative resections over an 8-year period were included to the study. Demographics, clinicopathological features, surgical as well as recurrence and survival outco...
Among a total of 493 surgically treated CRC cases, 104 patients were included to the study consisting of 68 (65.4%) men and 36 (34.6%) women with a median age of 64 (inter-quartile range: 55-74) years...
The LNR may be assessed as an adjunct to the current staging systems for the prediction of oncological outcomes and survival of surgically treated stage III CRC patients....
Although sentinel lymph node biopsy is now the primary method of axillary staging and is therapeutic for patients with limited nodal disease, axillary lymph node dissection (ALND) is still necessary f...
A 54-year-old woman who incidentally noticed a "knot" in her left breast subsequently underwent excisional biopsy which yielded a diagnosis of malignant neoplasm with sarcomatous features. Given the b...
Prostate cancer and bladder cancer accounts for approximately 13.5% and 3% of all male cancers and all newly diagnosed cancers (regardless sex), respectively. Thus, these cancers represent a major hea...
Remnant gastric cancer (RGC) is defined as a carcinoma that develops in the gastric remnant from 5 years after gastrectomy, regardless of the primary gastric disease. The pattern of lymph node dissemi...
In a total of 1380 patients with gastric cancer, between 1998 and 2020, 43 patients operated on for RGC were analyzed. The pattern of lymph node dissemination was evaluated based on the number of diss...
A mean of 13.0 ± 8.1 lymph nodes were dissected. The incidence of lymph node involvement by dissected station was higher at Stations 19, 11p, 3, 4sb and 7 (50, 40, 37.5, 36 and 31.7%, respectively). A...
There was no predilection for lymph node involvement when comparing the lesser and greater gastric curvature. The dissection of Stations 3, 4sb and 4sa is fundamental in surgical treatment with curati...
Lymph node (LN) harvesting is associated with outcomes in colonic cancer. We sought to interrogate whether a distinctive immune milieu of the primary tumour is associated with LN yield....
A total of 926 treatment-naive patients with colorectal adenocarcinoma with more than 12 LNs (LN-high) were compared with patients with 12 or fewer LNs (LN-low). We performed immunohistochemistry and ...
The LN-high group was comprised of younger patients, longer resections, larger tumours, right-sided location, and tumours with deficient mismatch repair (dMMR). The tumour microenvironment showed high...
Our findings corroborate that higher LN yield is associated with a survival benefit. LN yield is associated with an immune high microenvironment, suggesting that tumour immune milieu influences the LN...
In melanoma patients, surgical excision of the first draining lymph node, the sentinel lymph node (SLN), is a routine procedure to evaluate lymphogenic metastases. Metastasis detection by histopatholo...
In this multi-center study, a deep learning method was established on histological tissue sections of sentinel lymph nodes collected from the clinical routine. The algorithm was trained to highlight p...
The established method was able to detect the existence of metastasis on individual tissue cuts with an area under the curve of 0.9630 and 0.9856 respectively on two test cohorts from different labora...
Our results demonstrate that AI-based SLN melanoma metastasis detection has great potential and could become a routinely applied aid for pathologists. Our current study focused on assessing establishe...
